Discovery channel feed – Endpoints News

Discovery channel feed

The antibody discovery team at Twist bets on mouse model player in a boost to its portfolio

4 years ago

‘It’s a transformation’: Researchers are taking DeepMind’s groundbreaking protein folding software to places few predicted

4 years ago

Ligand to split in half, spinning OmniAb platform into its own company

4 years ago

Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs

4 years ago

Surgeons successfully attach pig kidney to a human for the first time, using tech from United's Revivicor

4 years ago

NIH spotlights trio of academic teams chasing after 'pan-coronavirus' vaccines

4 years ago

In step forward for rejuvenation field, researchers turn back the clock on mice hearts

4 years ago

UNC researchers report a new way to charge CAR-T against solid tumors

4 years ago

A new way to infiltrate (and destroy) some of the deadliest drug-resistant bugs

4 years ago

Looking for the next mRNA breakthrough, Moderna taps AbCellera in mysterious antibody discovery deal

4 years ago

Eli Lilly bets on an RNA base editing outfit leveraging the body's own enzymes to reverse mutations

4 years ago

Two Feng Zhang lab alumni find a new CRISPR enzyme that could take a Big Gulp out of RNA — and a raft of devastating diseases

4 years ago

Feng Zhang's lab develops potential breakthrough in RNA editing delivery using 'ultracompact' versions of Cas13

4 years ago

Feng Zhang unveils a new technology to potentially deliver mRNA, gene therapy, CRISPR and more

4 years ago

Searching for ways to boost CAR-T response, Penn researchers find a capable wingman in BET inhibitors

4 years ago

Google's DeepMind opens its protein database to science — potentially cracking drug R&D wide open

4 years ago

'They have shown that this is not some impossible thing': Academic lab copies Google’s big biological breakthrough

4 years ago

Controversial anti-aging scientist — backed by Harvard's George Church — makes a fresh round of claims on life extension in new mouse study

4 years ago

Relying on an ultra-rare variant, David Liu unveils a new approach to editing sickle cell

4 years ago

PureTech turns 200-year-old discovery into a new approach to Alzheimer's, while clinging to controversial amyloid hypothesis

5 years ago

Sanofi teams with virtual reality biotech on oral Dupixent successor

5 years ago

Novartis taps DNA damage specialist Artios in $1.3B discovery deal to complement growing radioligand portfolio

5 years ago

Stuart Lipton offers a new possible reason why all the Alzheimer's drugs have failed

5 years ago

Intellia announced a new tool for gene editing. Academics said they rewrote history

5 years ago

First page Previous page 1 2 345 6 7 Next page Last page